Immunization for prevention and treatment of cocaine abuse: Legal and ethical implications

Drug and Alcohol Dependence

Volumn 48, Issue 3, 1997, Pages 167-174

  Cohen, Peter J ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Addiction therapy; Cocaine vaccine; Law and ethics; Privacy and confidentiality; Stigmatization and discrimination

Indexed keywords

COCAINE; COCAINE VACCINE; UNCLASSIFIED DRUG; VACCINE;

DRUG DEPENDENCE; DRUG USE; HIGH RISK POPULATION; HUMAN; IMMUNIZATION; MEDICAL ETHICS; MEDICOLEGAL ASPECT; OFFENDER; PATIENT SELECTION; PRIORITY JOURNAL; PRIVACY; REVIEW;

EID: 0030834855     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(97)00075-6     Document Type: Article

References (36)

1. Alpert S. Smart cards, smarter policy. Medical records, privacy, and health care reform. Hastings Center Rep. 23:1993;13-23.
2. Beauchamp, T., Childress, J.F., 1994. Principles of Biomedical Ethics, 4th ed. Oxford University Press, New York, Oxford.
3. Carrera M.R.A., Ashley J.A., Parsons L.H., Wirsching P., Koob G.F., Janda K.D. Suppression of psychoactive effects of cocaine by active immunization. Nature. 378:1995;727-730.
4. Chavkin W. Mandatory treatment for drug use during pregnancy. J. Am. Med. Assoc. 266:1991;1556-1561.
5. Davis v. Berry et al. 216 F. 413, 416 (1914).
6. DeCrew J.W. Drug testing: balancing privacy and public safety. Hastings Center Rep. 24:1994;17-23.
7. Drug Use Forecasting, 1994. 1993 Annual report on adult arrestees: drugs and crime in America's cities. US Department of Justice, US Government Printing Office, Washington, DC.
8. Fulco, C.E., Liverman, C.T., Earley, L.E. (Eds.), 1995. Development of Medications for the Treatment of Opiate and Cocaine Addictions: Issues for the Government and Private Sector, Chapter 1. Institute of Medicine, National Academy Press, Washington, DC. pp. 26-42.
9. Gerberding J.L. The infected health care provider (editorial). New Engl. J. Med. 334:1996;594-595.
10. Ghent, J.F., 1995. Annotation: validity of statutes authorizing asexualization or sterilization of criminals or mental defectives. 53 A.L.R.3d 960.
11. Gostin L.O. Compulsory treatment for drug-dependent persons: justifications for a public health approach to drug dependency. Milbank Quart. 69:1991;561-593.
12. Gostin L.O. Health information privacy. Cornell L. Rev. 80:1995;451-528.
13. Gostin L.O. Tuberculosis and the power of the state: toward the development of rational standards for the review of compulsory public health powers. U. Chi. L. Sch. Roundtable. 2:1995;219-277.
14. Hall C.B. The recommended childhood immunization schedule of the United States. Pediatrics. 95:1995;135-137.
15. Harpaz R., Von Seidlein L., Averhoff F.M., Tormey M.P., Sinha S.D., Kotsopoulou K., Lambert S.B., Robertson B.H., Cherry J.D., Shapiro C.N. Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N. Engl. J. Med. 334:1996;549-554.
16. Jacobson v. Massachusetts 197 U.S. 11 (1905).
17. Kleber H.D. Naltrexone. J. Subst. Abuse Treat. 2:1985;117-122.
18. Kun J.-M. Rejecting the adage 'children should be seen and not heard'. Pace Law Rev. 16:1996;423-462.
19. Leshner A.I. Molecular mechanisms of cocaine addiction. New Engl. J. Med. 335:1996;128-129.
20. Leukefeld C.G., Tims F.M. Compulsory treatment for drug abuse. Int. J. Addict. 25:1990;621-640.
21. Marco C.H., Marco J.M. Antabuse: medication in exchange for a limited freedom - Is it legal? Am. J. Law Med. 5:1980;295-330.
22. Mendelson J.H., Mello N.K. Management of cocaine abuse and dependence. New Engl. J. Med. 334:1996;965-972.
23. National Commission for Protection of Human Subjects of Biomedical and Behavioral Research, 1979. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects in Research, OPRR Reports, National Institutes of Health, Bethesda, MD.
24. Nicholson R.H. U.K. moves toward compulsory vaccination. Hastings Center Rep. 20:1996;4.
25. Nutt D.J. Addiction: brain mechanisms and their treatment implications. Lancet. 347:1996;31-36.
26. O'Brien C.P. Myths about the treatment of addiction. Lancet. 347:1996;237-240.
27. Olmsted v. United States, 277 U.S. 438, 478 (1928) (Brandeis, J., dissenting).
28. Polizzi C.M. A proposal for a federal AIDS immunization policy. J. Law Health. 9:1994;1-40.
29. Robinson v. California, 370 U.S. 660 (1962).
30. Schloendorff v. The Society of the New York Hospital, 211 N.Y. 125, 129, 105 N.E. 92, 93 (1914).
31. Self D.W. Cocaine abuse takes a shot. Nature. 378:1995;666-667.
32. Smith T.W., Butler V.P. Jr., Haber E., Fozzard H., Marcus F.I., Bremner W.F., Schulman I.C., Phillips A. Treatment of life-threatening digitalis intoxication with digoxin-specific Fab fragments: experience in 26 cases. New Engl. J. Med. 307:1982;1357-1362.
33. Smith T.W., Haber E., Yeatman L., Butler V.P. Jr. Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies. New Engl. J. Med. 294:1976;797-800.
34. Stern, C., 1996. California waging war on sexual predators; chemical castration law is state's latest weapon. The Washington Post, September 24, page A3.
35. Tarasoff v. Regents of the University of California, 551 P.2d 334, 340, 344 (1976) (en banc).
36. Weinstein S.P., Gottheil E. E., Sterling R.C., DeMaria P.A. Jr. Long-term methadone maintenance treatment: some clinical examples. J. Subst. Abuse Treat. 10:1993;277-281.